Why TRT Raised Your Blood Pressure (and How to Fix It)
Your cardiovascular system is built around a very specific volume of blood, and testosterone changes that volume, and the pressure in your vessels goes up or down depending on how your body handles those changes.
That is the whole system. Three separate mechanisms, three separate levers, and if you do not know which one is driving your blood pressure up, you cannot fix it.
Start with the most common one.
Testosterone stimulates your kidneys and bone marrow to produce more red blood cells, and it does this in a dose-dependent way, meaning the more testosterone you take, the more red blood cells your body makes. The technical name for this is erythrocytosis, which is just an elevated red cell count above normal range. Research tracking men across graded testosterone doses showed that hemoglobin and hematocrit rose in a linear fashion as doses increased, with no plateau, so there is no ceiling where your body stops responding.
Why does this raise blood pressure? Think of your blood vessels like a garden hose. If you thicken the fluid running through that hose, the pump has to work harder to push it through, and the pressure inside the hose goes up. Thicker blood creates more resistance, and your heart compensates by generating more force.
A randomized controlled trial measured exactly how much this matters. Men whose hematocrit rose more than 6% on testosterone therapy saw their systolic blood pressure increase by 13.2 millimeters of mercury compared to placebo. That is not a small shift. That is the kind of increase a doctor would want to treat with medication.
The number to watch is 54%. Current clinical guidelines indicate that a hematocrit above 54% is the threshold where a dose reduction or temporary discontinuation is warranted. Below that, you are managing a trend. Above it, you have a problem that needs an active response.
This is also why checking labs every six months matters more than most people think. Hematocrit does not spike overnight. It creeps up, and by the time you feel anything, the number has been elevated for a while.
The second mechanism is estradiol, and this one is where a lot of clinic protocols make the situation worse rather than better.
Testosterone does not stay as testosterone. Your body converts a portion of it into estradiol through a process called aromatization, which is the conversion of androgens into estrogens by an enzyme called aromatase. Estradiol then acts on your kidneys and renal tubules to retain sodium and water, which increases extracellular fluid volume, which raises blood pressure. Research on testosterone therapy specifically found that it independently increased extracellular water through this renal mechanism, separate from any other effect.
So the instinct is to suppress estradiol. That is what aromatase inhibitors do, and many men are prescribed them automatically when their estradiol comes back elevated. The problem is that estradiol is not just a side effect to be minimized. It plays a direct protective role in cardiovascular function, and when you suppress it too aggressively, blood pressure goes up from the other direction.
Animal research on aromatase inhibition showed that blocking the enzyme increased mean arterial pressure and produced markers of kidney injury. The mechanism is still being worked out, but the practical implication is clear: you cannot treat estradiol as simply too high or too low. You need it in a window, specifically somewhere around 20 to 40 picograms per milliliter on a sensitive estradiol assay.
The way you hold it in that window without reaching for an aromatase inhibitor is by adjusting injection frequency. More frequent, smaller injections produce less of a testosterone spike, which means less substrate for aromatization, which means less estradiol conversion without chemically suppressing the enzyme. It is a slower, less dramatic fix, but it does not carry the risk of crashing the estradiol that is protecting your cardiovascular system.
The third mechanism is the one that has nothing to do with your labs and everything to do with what you are doing outside the clinic.
Testosterone increases blood volume. More red cells, more fluid, more circulating volume overall. Your cardiovascular system is designed to adapt to changes in demand, but that adaptation requires stress, meaning the kind of stress that comes from using the system at higher outputs, meaning cardio. Without it, your heart and vessels do not develop the capacity to efficiently handle the increased load, and pressure builds.
This is not a subtle effect. Your cardiac output, stroke volume, and vascular compliance all respond to aerobic training in ways that directly lower resting blood pressure. A cardiovascular system that is being trained is a cardiovascular system that is expanding its ability to handle what testosterone is putting into it. One that is not being trained is just absorbing the increased volume without adaptation.
Now here is what changes the picture entirely, and this is why the framing of TRT as something that raises blood pressure is incomplete.
When these three mechanisms are actively managed, testosterone therapy does not raise blood pressure. It lowers it. A study following 737 men on long-term testosterone replacement found that men not on antihypertensive medication saw their systolic pressure drop by approximately 12.5 millimeters of mercury. In a separate cohort of 202 men, 33 who had been taking blood pressure medication were able to discontinue it entirely over the course of the treatment period.
The mechanism behind that benefit is the same biology that causes the problem when it is unmanaged. Testosterone improves insulin sensitivity, reduces visceral fat, improves vascular function, and increases cardiac output when paired with physical activity. All of those things lower blood pressure.
The men who see their pressure rise on TRT are not experiencing a drug side effect in the traditional sense. They are experiencing the consequence of a system that was changed without being managed, which is a different problem with a different solution.
Most cardiovascular risk on testosterone therapy is preventable. The three levers are real and the adjustments are specific: keep hematocrit below 54%, keep estradiol in range without suppressing it, and give your cardiovascular system the training it needs to handle the volume it is now carrying.
The biology is working in your favor when you let it.
References
- Olesen TB, Glintborg D, Johnk F, et al. 2024. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency. Journal of Hypertension, 423, 531-540. Finding: Office SBP increased 6.2 mmHg in testosterone group vs 7.0 mmHg decrease in placebo net 13.2 mmHg. Men with hematocrit rise >6% saw clinically relevant BP increases. Source
- Coviello AD, Kaplan B, Lakshman KM, et al. 2008. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology and Metabolism, 933, 914-919. Finding: Hemoglobin and hematocrit increased in a linear, dose-dependent fashion. Source
- Almutlaq RN, Newell-Fugate AE, Evans LC, et al. 2022. Aromatase inhibition increases blood pressure and markers of renal injury in female rats. American Journal of Physiology Renal Physiology, 3232, F170-F181. Finding: Blocking aromatase increased mean arterial pressure. Source
- Hackett G, Mann A, Haider A, et al. 2024. Testosterone replacement therapy: effects on blood pressure in hypogonadal men. World Journal of Mens Health, 422, 431-443. Finding: Long-term TRT associated with significant SBP and DBP reductions. 33 of 202 men on antihypertensives discontinued them. Source
- Agrawal P, Singh SM, Kohn T. 2023. Management of erythrocytosis in men receiving testosterone therapy. European Urology Focus, 91, 139-142. Finding: Hematocrit >54% requires dose decrease or discontinuation. Source
- Johannsson G, Gibney J, Wolthers T, et al. 2005. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. Journal of Clinical Endocrinology and Metabolism, 907, 3891-3896. Finding: Testosterone independently increased extracellular water through renal tubule effects. Source
Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness
If this is the kind of information you want access to on a daily basis, the community is free and there are full courses on training, nutrition, hormones, and supplementation inside. You can ask questions and post your own labs and get feedback from me and from the community.